RROM (NAM E LO CATI ON .RHONE) Dept, of Medicine & Environmental Health SUBJECT: January 17, 1983 TCDD ca F.R.

r JU R IS DOCTOR.

Voijpft .. oe 'JSpim>`- ile :vMVsi ^iQg Ht HjTfefTf ' f &'j^>^s i .u'* Brasa?

*' *' M onsanto Chemical C ompany St .

c REPORT TO THE JANUARY MEETING CF THE BOARD OF DIRECTORS ON THE STATUS C?

IEEE Symposium on E le c tric a l In su la tio n , Montreal, Quebec, Canada June 1976 a flammability test fob dielectric fluids L.

-iird'iii VI t . . v ( .

MONSANTO Oct.22,1992 PRODUCTION DOCUMENTS FOLDER #6 NPC BATES #701852 DEF BATES# Nv 002614 TO NPC BATES #702392 DEF BATES# Nv 003154 ] MONSANTO COMPANY 8T.

Telephone: (702) 385-4202 BRADLEY & MERRELL c/o Jones, Jones, Close & Brown 300 South Fourth Street, Seventh Floor Las Vegas, Nevada 89101-6026 Telephone: (702) 385-4202 Fax: (702) 384-2276 (702) 384-0479 Fax: (702) 384-0479 February 22, 1993 HAND DELIVERED Sue Fogleboch, CLA Nevada Power Company 6226 West Sahara Avenue Las Vegas, Nevada 89102 R e : Nevada Power Company v.

Telephone: (702) 385-4202 cB/oRJAonDesL, EJoYnes&, CMloEseR&REBrLowLn 300 South Fourth Street, Seventh Floor Las Vegas, Nevada 89101-6026 Fax: (702) 385-1655 June 21, 1993 VIA TELEFAX John Kim, Esq.

Telephone: (702) 385-4202 BRADLEY & MERRELL c/o Jones, Jones, Close & Brown 300 South Fourth Street, Seventh Floor Las Vegas, Nevada 89101-6026 Fax: (702) 385-1655 July 21, 1993 Manning Gilbert Warren, III School of Law University of Louisville Louisville, Kentucky 40292 Re: Nevada Power Company v.

SENT BY*ATTORNEYS AT LAW 7- 6-83 U:09 !

< : . r* .Monsanto '*i- -*- *4<er trfK X t TO N.

CERTIFICATE OF SERVICE I , W.

MEMORANDUM TO: FROM: DATE: RE: Montante File 212(a) DLK A u gu st 8, 1384 Reconciliation of plaintiff' raquatt for chloracne document on 219 people with Zeck/Susklnd Mortality Study Cohort Some month ago plaintiffs supplemented a request for production of raw data of mortality studies b y providing a list of 219 names for whom they sought certain Information, including any record showing that each person had (1) a "true cate of chloracne" as defined in the Zack/Suskind mortality study, or (2) a diagnosis of chloracn, rash or 2,4,5-T rash subsequent to March 8, 1949, through the end of 1952.